Larimar Therapeutics, Inc. (LRMR) › Net IncomeLarimar Therapeutics, Inc. (LRMR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$13.88M2013: -$14.03M2014: -$36.48M2015: -$74.29M2016: -$57.88M2017: -$52.03M2018: -$61.37M2019: -$23.13M2020: -$42.48M2021: -$50.64M2022: -$35.35M2023: -$36.95M2024: -$80.60M2025: -$165.67M-$165.67M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$165.67M-105.5%2024-$80.60M-118.1%2023-$36.95M-4.5%2022-$35.35M+30.2%2021-$50.64M-19.2%2020-$42.48M-83.7%2019-$23.13M+62.3%2018-$61.37M-18.0%2017-$52.03M+10.1%2016-$57.88M+22.1%2015-$74.29M-103.6%2014-$36.48M-160.1%2013-$14.03M-1.1%2012-$13.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share